Drug Shortage Report for KETALAR

Last updated on 2022-03-08 History
Report ID 150702
Drug Identification Number 00224405
Brand name KETALAR
Common or Proper name KETALAR 50MG
Company Name ERFA CANADA 2012 INC
Market Status MARKETED
Active Ingredient(s) KETAMINE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size VIAL 10ML
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-12-10
Actual start date
Estimated end date 2022-01-31
Actual end date 2022-03-03
Shortage status Resolved
Updated date 2022-03-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1600 NOTRE DAME ST. WEST
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-03-08 French Compare
v4 2022-03-08 English Compare
v3 2021-12-11 English Compare
v2 2021-12-08 French Compare
v1 2021-12-08 English Compare

Showing 1 to 5 of 5